# Chime Financial, Inc.: financial statements, quarterly

CHYM · Nasdaq · CIK 1795586 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/chym.md) · [Financials](/companies/chym/financials.md) · [Filings](/companies/chym/filings.md) · [Insiders](/companies/chym/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/chym/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [384](/filings/0001795586-25-000009.md) | [422](/filings/0001795586-25-000019.md) | [475 d](/filings/0001795586-26-000013.md) | [519](/filings/0001795586-26-000038.md) | [528](/filings/0001795586-26-000048.md) | [544](/filings/0001795586-25-000019.md) | [596 d](/filings/0001795586-26-000013.md) | [647](/filings/0001795586-26-000038.md) | [670](/filings/0001795586-26-000048.md) |
| Cost of revenue | $m | not reported | [50.5](/filings/0001795586-25-000009.md) | [53.5](/filings/0001795586-25-000019.md) | [56.0 d](/filings/0001795586-26-000013.md) | [60.4](/filings/0001795586-26-000038.md) | [67.1](/filings/0001795586-26-000048.md) | [69.4](/filings/0001795586-25-000019.md) | [66.1 d](/filings/0001795586-26-000013.md) | [67.1](/filings/0001795586-26-000038.md) | [74.9](/filings/0001795586-26-000048.md) |
| Gross profit | $m | not reported | [334](/filings/0001795586-25-000009.md) | [368](/filings/0001795586-25-000019.md) | [419 d](/filings/0001795586-26-000013.md) | [458](/filings/0001795586-26-000038.md) | [461](/filings/0001795586-26-000048.md) | [474](/filings/0001795586-25-000019.md) | [530 d](/filings/0001795586-26-000013.md) | [580](/filings/0001795586-26-000038.md) | [595](/filings/0001795586-26-000048.md) |
| Research and development | $m | not reported | [75.4](/filings/0001795586-25-000009.md) | [80.4](/filings/0001795586-25-000019.md) | [78.9 d](/filings/0001795586-26-000013.md) | [77.9](/filings/0001795586-26-000038.md) | [622](/filings/0001795586-26-000048.md) | [124](/filings/0001795586-25-000019.md) | [111 d](/filings/0001795586-26-000013.md) | [110](/filings/0001795586-26-000038.md) | [112](/filings/0001795586-26-000048.md) |
| Operating income | $m | not reported | [(9.4)](/filings/0001795586-25-000009.md) | [(30.6)](/filings/0001795586-25-000019.md) | [(27.1) d](/filings/0001795586-26-000013.md) | [9.1](/filings/0001795586-26-000038.md) | [(931)](/filings/0001795586-26-000048.md) | [(64.7)](/filings/0001795586-25-000019.md) | [(53.8) d](/filings/0001795586-26-000013.md) | [46.2](/filings/0001795586-26-000038.md) | [21.3](/filings/0001795586-26-000048.md) |
| Income tax | $m | not reported | [0.1](/filings/0001795586-25-000009.md) | [2.2](/filings/0001795586-25-000019.md) | [0.7 d](/filings/0001795586-26-000013.md) | [1.6](/filings/0001795586-26-000038.md) | [(1.0)](/filings/0001795586-26-000048.md) | [0.3](/filings/0001795586-25-000019.md) | [0.0 d](/filings/0001795586-26-000013.md) | [0.5](/filings/0001795586-26-000038.md) | [0.2](/filings/0001795586-26-000048.md) |
| Net income | $m | [15.9](/filings/0001795586-25-000019.md) | [0.4](/filings/0001795586-25-000019.md) | [(22.0)](/filings/0001795586-25-000019.md) | [(19.6) d](/filings/0001795586-26-000013.md) | [12.9](/filings/0001795586-26-000048.md) | [(923)](/filings/0001795586-26-000048.md) | [(54.7)](/filings/0001795586-25-000019.md) | [(44.8) d](/filings/0001795586-26-000013.md) | [53.5](/filings/0001795586-26-000048.md) | [27.9](/filings/0001795586-26-000048.md) |
| Diluted EPS | $ per share | not reported | [0.00](/filings/0001795586-25-000009.md) | [(0.34)](/filings/0001795586-25-000019.md) | not reported | [0.00](/filings/0001795586-26-000038.md) | [(7.29)](/filings/0001795586-26-000048.md) | [(0.15)](/filings/0001795586-25-000019.md) | not reported | [0.13](/filings/0001795586-26-000038.md) | [0.07](/filings/0001795586-26-000048.md) |
| Basic EPS | $ per share | not reported | [0.00](/filings/0001795586-25-000009.md) | [(0.34)](/filings/0001795586-25-000019.md) | not reported | [0.00](/filings/0001795586-26-000038.md) | [(7.29)](/filings/0001795586-26-000048.md) | [(0.15)](/filings/0001795586-25-000019.md) | not reported | [0.14](/filings/0001795586-26-000038.md) | [0.07](/filings/0001795586-26-000048.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [240](/filings/0001795586-26-000013.md) | not reported | [295](/filings/0001795586-25-000009.md) | [271](/filings/0001795586-25-000019.md) | [338](/filings/0001795586-26-000013.md) | [318](/filings/0001795586-26-000038.md) | [868](/filings/0001795586-26-000048.md) | [445](/filings/0001795586-25-000019.md) | [466](/filings/0001795586-26-000048.md) | [608](/filings/0001795586-26-000038.md) | [536](/filings/0001795586-26-000048.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [1,287](/filings/0001795586-26-000013.md) | not reported | [1,736](/filings/0001795586-25-000009.md) | [1,759](/filings/0001795586-25-000019.md) | [1,756](/filings/0001795586-26-000048.md) | [1,744](/filings/0001795586-26-000038.md) | [1,790](/filings/0001795586-26-000048.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [1,461](/filings/0001795586-26-000013.md) | not reported | [1,902](/filings/0001795586-25-000009.md) | [1,962](/filings/0001795586-25-000019.md) | [1,965](/filings/0001795586-26-000048.md) | [1,950](/filings/0001795586-26-000038.md) | [1,997](/filings/0001795586-26-000048.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [375](/filings/0001795586-26-000013.md) | not reported | [360](/filings/0001795586-25-000009.md) | [356](/filings/0001795586-25-000019.md) | [388](/filings/0001795586-26-000048.md) | [344](/filings/0001795586-26-000038.md) | [387](/filings/0001795586-26-000048.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [502](/filings/0001795586-26-000013.md) | not reported | [474](/filings/0001795586-25-000009.md) | [519](/filings/0001795586-25-000019.md) | [563](/filings/0001795586-26-000048.md) | [509](/filings/0001795586-26-000038.md) | [592](/filings/0001795586-26-000048.md) |
| Shareholders' equity | $m | [(1,789)](/filings/0001795586-26-000013.md) | [(1,954)](/filings/0001795586-26-000013.md) | [(1,934)](/filings/0001795586-25-000019.md) | [(1,909)](/filings/0001795586-25-000019.md) | [(1,917)](/filings/0001795586-25-000019.md) | [(1,931)](/filings/0001795586-26-000048.md) | [(1,908)](/filings/0001795586-26-000048.md) | [1,428](/filings/0001795586-26-000048.md) | [1,443](/filings/0001795586-25-000019.md) | [1,402](/filings/0001795586-26-000048.md) | [1,441](/filings/0001795586-26-000048.md) | [1,405](/filings/0001795586-26-000048.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(24.9) d](/filings/0001795586-25-000019.md) | [18.2 d](/filings/0001795586-26-000013.md) | [(25.8)](/filings/0001795586-26-000038.md) | [28.5 d](/filings/0001795586-26-000048.md) | [17.5 d](/filings/0001795586-25-000019.md) | [32.6 d](/filings/0001795586-26-000013.md) | [87.5](/filings/0001795586-26-000038.md) | [207 d](/filings/0001795586-26-000048.md) |
| Capital expenditure | $m | [3.1 d](/filings/0001795586-25-000019.md) | [1.6 d](/filings/0001795586-26-000013.md) | [1.6](/filings/0001795586-26-000038.md) | [2.0 d](/filings/0001795586-25-000009.md) | [2.1 d](/filings/0001795586-25-000019.md) | [14.2 d](/filings/0001795586-26-000013.md) | [6.6](/filings/0001795586-26-000038.md) | [9.9 d](/filings/0001795586-26-000048.md) |
| Share repurchases | $m | [0.4 d](/filings/0001795586-25-000019.md) | [0.0 d](/filings/0001795586-26-000013.md) | [0.0](/filings/0001795586-26-000038.md) | [0.0 d](/filings/0001795586-26-000048.md) | [0.0 d](/filings/0001795586-25-000019.md) | [77.5 d](/filings/0001795586-26-000013.md) | [85.7](/filings/0001795586-26-000038.md) | [136 d](/filings/0001795586-26-000048.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment, us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [64.7](/filings/0001795586-25-000009.md) | [65.1](/filings/0001795586-25-000019.md) | [65.9](/filings/0001795586-26-000038.md) | [127](/filings/0001795586-26-000048.md) | [372](/filings/0001795586-25-000019.md) | [400](/filings/0001795586-26-000038.md) | [393](/filings/0001795586-26-000048.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.